Abstract:Abstract Background IBD is characterized by relapsing episodes of tissue-damaging inflammation in the gastrointestinal tract. Abdominal pain is common in IBD and often persists in the absence of overt inflammation. The treatment has limited efficacy, in part due to our partial understanding of its pathophysiology, and thus commonly leads to dependency on opioids. Moreover, patients with IBD are more likely to develop psychiatric comorbidities (anxiety and depression), further impairing the disease course and quality of life. The gut microbiota has been shown to modulate pain, mood, and anxiety. Gut bacterial composition and function are altered in patients with IBD. However, whether IBD microbiota affects pain perception and emotional behaviour is unknown. Aims To determine whether microbiota from patients with IBD contributes to visceral hypersensitivity and behavioural abnormalities in a microbiota-humanized mouse model. Methods Adult germ-free C57BL/6 mice (n=65) of both sexes were colonized with fecal microbiota from 7 patients with IBD (Crohn’s Disease n=5, Ulcerative Colitis n=2) and 3 healthy controls (HC). Mice were fed with a human-like (Western) diet. Behavioural tests (light preference, open field, and tail suspension tests) were employed to assess anxiety- and depression-like behaviour. Visceral sensitivity was assessed by measuring visceromotor responses to colorectal distension. Results Compared to mice with HC microbiota, mice with IBD microbiota had reduced body weight gain. However, no differences in colon length were found, suggesting that IBD microbiota did not induce overt colonic inflammation. Mice with IBD microbiota displayed a reduced preference for the light chamber and increased immobility in the tail suspension test compared to HC mice, suggestive of anxiety- and depression-like behaviour, respectively. Importantly, no differences in overall locomotion were observed, thus ruling out sickness-like behaviour. When subjected to colorectal distension, mice with IBD microbiota had an overall higher visceromotor response (area under the curve) compared to HC mice. Furthermore, they displayed increased responses to non-noxious stimuli (100 μL distension), suggestive of visceral allodynia. Conclusions Our data demonstrate that microbiota from patients with IBD negatively affects the gut-brain axis, by inducing changes in emotionality-related behaviour and triggering visceral hypersensitivity. Uncovering the microbial products and molecular mechanisms underlying these abnormalities will guide the development of novel microbiota-based therapies for patients with IBD. Funding Agencies CCC, CIHRCrohn's and Colitis Foundation (USA)

Pivotal Role of the Gut Microbiota in Congenital Insensitivity to Pain with Anhidrosis

Two Novel<i>SCN9A</i>Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

The Role of the Gut–microbiota–brain Axis Via the Subdiaphragmatic Vagus Nerve in Chronic Inflammatory Pain and Comorbid Spatial Working Memory Impairment in Complete Freund's Adjuvant Mice

Gut Microbiota Influences Neuropathic Pain Through Modulating Proinflammatory and Anti-inflammatory T Cells

Aggregation and Self-Assembly of Hydrophobins from Trichoderma Reesei: Low-Resolution Structural Models

Key Role of Gut Microbiota in Anhedonia-Like Phenotype in Rodents with Neuropathic Pain.

Inhibitory effects of antibiotic-induced gut microbiota depletion on acute itch behavior in mice

Heterogeneity of Clinical Features and Mutation Analysis of NTRK1 in Han Chinese Patients with Congenital Insensitivity to Pain with Anhidrosis

Pain Regulation by Gut Microbiota: Molecular Mechanisms and Therapeutic Potential

A network approach to investigating the key microbes and stability of gut microbial communities in a mouse neuropathic pain model

Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies

Integration of microbiota and metabolomics reveals the analgesic mechanisms of emodin against neuropathic pain

Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization

Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice with Cognitive Dysfunction Induced by Chronic Neuropathic Pain

Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice

Genetic etiology study in a large cohort with congenital insensitivity to pain with anhidrosis

Living without pain: A 10-year study of congenital insensitivity to pain with anhidrosis

Gut-innervating nociceptors regulate the intestinal microbiota to promote tissue protection

[Progress in the diagnosis and treatment of Congenital insensitivity to pain with anhidrosis]

A13 MICROBIOTA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) INDUCE ALTERED BEHAVIOUR AND VISCERAL HYPERSENSITIVITY IN MICROBIOTA-HUMANIZED MICE

Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature